Induction of the peroxisome proliferator activated receptor by fenofibrate in rat liver
Open accessAbstract
The process of peroxisome proliferation in rodent liver by hypolipidemic compounds and related substances has recently been shown to be receptor‐madiated. In the present study, we have examined the effect of oral administration of the strong peroxisome proliferator fenofibrate on the hepatic expression level of the peroxisome proliferator activated receptor (PPAR) in rats. Immunoblots of rat liver cytosols and nuclear extracs using antibodies raised against recombinant PPAR/β‐galactosidase fusion proteins revealed a pronounced increase in the amount of PPAR protein in response to fenofibrate treatment. This induction could also be confirmed at the level or RNA by Northern blotting. A time‐course investigation showed a delayed accumulation of mRNA in response to the treatment, starting on day 2 after a latency period of at least one day. Thus, induction of the PPAR as a response to peroxisome proliferators represents one important dimension of the pleiotropic effects of peroxisome proliferators.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Fenofibrate's basic mechanism of action involves PPAR-α agonist activity resulting in altered transcription of several genes.
“Although FF’s basic mechanism of action is known to involve PPAR-α agonist activity resulting in altered transcription of several genes, the actual genetic bases for variability in lipid response is poorly understood.”
From Fenofibrate and metabolic syndrome (2010) · cites this paper as [17]
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302 · see citing works
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589 · see citing works
Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1006/abio.1987.9999 · Cited by 65,240 · see citing works
Towbin, H., Staehelin, T., & Gordon, J. (1979) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.76.9.4350 · Cited by 51,421 · see citing works
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczyński, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 47,092 · see citing works
Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA Polymerase
Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Horn, G. T., Mullis, K. B., & Erlich, H. A. (1988) · Science · doi:10.1126/science.2448875 · Cited by 17,719 · see citing works
Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
Issemann, I., & Green, S. (1990) · Nature · doi:10.1038/347645a0 · Cited by 3,519 · see citing works
Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors
Dreyer, C., Krey, G. D., Keller, H., Givel, F., Helftenbein, G., & Wahli, W. (1992) · Cell · doi:10.1016/0092-8674(92)90031-7 · Cited by 1,373 · see citing works
Tugwood, J. D., Issemann, I., Anderson, R. G., Bundell, K. R., McPheat, W. L., & Green, S. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05072.x · Cited by 895 · see citing works
Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens
Reddy, J. K., Azarnoff, D. L., & Hignite, C. E. (1980) · Nature · doi:10.1038/283397a0 · Cited by 835 · see citing works
NATURE OF THE HEPATOMEGALIC EFFECT PRODUCED BY ETHYL-CHLOROPHENOXY-ISOBUTYRATE IN THE RAT
Hess, R., Stäubli, W., & RIESS, W. (1965) · Nature · doi:10.1038/208856a0 · Cited by 596 · see citing works
Stanley, K. K., & Luzio, J. P. (1984) · The EMBO Journal · doi:10.1002/j.1460-2075.1984.tb01988.x · Cited by 539 · see citing works
HEPATIC AND RENAL EFFECTS OF PEROXISOME PROLIFERATORS: BIOLOGICAL IMPLICATIONS*
Reddy, J. K., Warren, J. R., Reddy, M. K., & Lalwani, N. D. (1982) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1982.tb21409.x · Cited by 233 · see citing works
Gibson, G. G., Orton, T. C., & Tamburini, P. P. (1982) · Biochemical Journal · doi:10.1042/bj2030161 · Cited by 221 · see citing works
Lalwani, N. D., Alvares, K., Reddy, M. K., Reddy, M. N., Parikh, I., & Reddy, J. K. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.15.5242 · Cited by 95 · see citing works
Alvares, K., Carrillo, A., Yuan, P. M., Kawano, H., Morimoto, R. I., & Reddy, J. K. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.14.5293 · Cited by 78 · see citing works
Milton, M., ElcombeP, C. R., Kass, G. E. N., & Gibson, G. G. (1988) · Biochemical Pharmacology · doi:10.1016/0006-2952(88)90163-3 · Cited by 34 · see citing works
Waechter, F., Bieri, F., Stäubli, W., & Bentley, P. (1984) · Biochemical Pharmacology · doi:10.1016/0006-2952(84)90366-6 · Cited by 28 · see citing works
[19] Production of site-specific P450 antibodies using recombinant fusion proteins as antigens
Friedberg, T., Kissel, W., Arand, M., & Oesch, F. (1991) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(91)06090-p · Cited by 8 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Lee, S. S. T., Pineau, T., Drago, J., Lee, E. J., Owens, J. W., Kroetz, D. L., Fernández‐Salguero, P. M., Westphal, H., & Gonzalez, F. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.6.3012 · Cited by 1,655 · see citing works
Schoonjans, K., Staels, B., & Auwerx, J. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42003-6 · Cited by 1,216 · see citing works
Schoonjans, K., Staels, B., & Auwerx, J. H. (1996) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(96)00066-5 · Cited by 1,047 · see citing works
Gulick, T., Cresci, S., Caira, T., Moore, D. D., & Kelly, D. P. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.11012 · Cited by 560 · see citing works
Brandt, J. M., Djouadi, F., & Kelly, D. P. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.37.23786 · Cited by 456 · see citing works
Dekker, M. J., Su, Q., Baker, C., Rutledge, A. C., & Adeli, K. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00283.2010 · Cited by 419 · see citing works
Tsubouchi, Y., Sano, H., Kawahito, Y., Mukai, S., Yamada, R., Kohno, M., Inoue, K., Hla, T., & Kondo, M. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2436 · Cited by 309 · see citing works
Diverse compounds mimic Alzheimer disease–causing mutations by augmenting Aβ42 production
Kukar, T. L., Murphy, M. P., Eriksen, J. L., Sagi, S. A., Weggen, S., Smith, T. E., Ladd, T. B., Khan, M. A., Kache, R., Beard, J. D., et al. (2005) · Nature Medicine · doi:10.1038/nm1235 · Cited by 284 · see citing works
Inoue, I., Goto, S.-I., Matsunaga, T., Nakajima, T., Awata, T., Hokari, S., Komoda, T., & Katayama, S. (2001) · Metabolism · doi:10.1053/meta.2001.19415 · Cited by 283 · see citing works
Latruffe, N., & Vamecq, J. (1997) · Biochimie · doi:10.1016/s0300-9084(97)81496-4 · Cited by 237 · see citing works
Chawla, A., & Lazar, M. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.5.1786 · Cited by 227 · see citing works
Impairment of hepatic Stat-3 activation and reduction of PPARα activity in fructose-fed rats
Roglans, N., Vilà, L., Farré, M., Alegret, M., Sánchez, R. M., Vázquez‐Carrera, M., & Laguna, J. C. (2007) · Hepatology · doi:10.1002/hep.21499 · Cited by 221 · see citing works
A role for Sp and nuclear receptor transcription factors in a cardiac hypertrophic growth program
Sack, M. N., Disch, D. L., Rockman, H. A., & Kelly, D. P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6438 · Cited by 206 · see citing works
Inoue, I., Shino, K., Noji, S., Awata, T., & Katayama, S. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8622 · Cited by 199 · see citing works
Levy, C., Peter, J. A., Nelson, D. R., Keach, J., Petz, J., Cabrera, R., Clark, V., Firpi, R. J., Morelli, G., Soldevila-Pico, C., et al. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04512.x · Cited by 186 · see citing works
Horowitz, J. F., Leone, T. C., Feng, W., Kelly, D. P., & Klein, S. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.279.2.e348 · Cited by 181 · see citing works
Huss, J. M., Levy, F. H., & Kelly, D. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100277200 · Cited by 174 · see citing works
Role of peroxisome proliferator-activated receptor α in disease of pancreatic β cells
Zhou, Y.-T., Shimabukuro, M., Wang, M.-Y., Lee, Y., Higa, M., Milburn, J. L., Newgard, C. B., & Unger, R. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8898 · Cited by 173 · see citing works
Peters, J. M. (1998) · Carcinogenesis · doi:10.1093/carcin/19.11.1989 · Cited by 161 · see citing works
Asp333, Asp495, and His52.3 Form the Catalytic Triad of Rat Soluble Epoxide Hydrolase
Arand, M., Wagner, H., & Oesch, F. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.8.4223 · Cited by 137 · see citing works
Self-citationJalouli, M., Carlsson, L., Améen, C., Lindén, D., Ljungberg, A., Michalik, L., Edén, S., Wahli, W., & Oscarsson, J. (2002) · Endocrinology · doi:10.1210/en.2002-220630 · Cited by 131 · see citing works
Transcriptional and phenotypic comparisons of Ppara knockout and siRNA knockdown mice
Souza, A. T. D., Dai, X., Spencer, A. G., Reppen, T. W., Menzie, A. M., Roesch, P. L., He, Y. D., Caguyong, M. J., Bloomer, S., Herweijer, H., et al. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl609 · Cited by 110 · see citing works
Pineau, T., Hudgins, W. R., Liu, L., Chen, L., Sher, T., Gonzalez, F. J., & Samid, D. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(96)00340-1 · Cited by 110 · see citing works
Schoonjans, K., Staels, B., Grimaldi, P. A., & Auwerx, J. H. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb18181.x · Cited by 109 · see citing works
Lens, S., Leoz, M., Nazal, L., Bruguera, M., & Parés, A. (2014) · Liver International · doi:10.1111/liv.12290 · Cited by 107 · see citing works
Fenofibrate for patients with asymptomatic primary biliary cirrhosis
Dohmen, K., Mizuta, T., Nakamuta, M., Shimohashi, N., Ishibashi, H., & Yamamoto, K. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i6.894 · Cited by 99 · see citing works
Central role of PPARα in the mechanism of action of hepatocarcinogenic peroxisome proliferators
Corton, J. C., Lapinskas, P. J., & Gonzalez, F. J. (2000) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(99)00232-8 · Cited by 99 · see citing works
Kopf, D., Westphal, S., Luley, C. W., Ritter, S., Gilles, M., Weber-Hamann, B., Lederbogen, F., Lehnert, H., Henn, F. A., Heuser, I., et al. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000138762.23482.63 · Cited by 92 · see citing works
Lindén, D., Lindberg, K., Oscarsson, J., Claesson, C., Asp, L., Lu, L., Gustafsson, M. V., Borén, J., & Olofsson, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110416200 · Cited by 92 · see citing works
Barbiero, J. K., Santiago, R. M., Persike, D. S., Fernandes, M. J. D. S., Tonin, F. S., Cunha, C. D., Boschen, S. L., Lima, M. M. S., & Vital, M. A. B. F. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.08.014 · Cited by 90 · see citing works
Ibabe, A., Bilbao, E., & Cajaraville, M. P. (2004) · Histochemistry and Cell Biology · doi:10.1007/s00418-004-0737-2 · Cited by 83 · see citing works
Serisier, S., Leray, V., Poudroux, W., Magot, T., Ouguerram, K., & Nguyen, P. (2007) · British Journal Of Nutrition · doi:10.1017/s0007114507862386 · Cited by 80 · see citing works
Jones, P. S., Savory, R., Barratt, P., Bell, A. R., Gray, T. J. B., Jenkins, N. A., Gilbert, D. J., Copeland, N. G., & Bell, D. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.219_1.x · Cited by 78 · see citing works
Clemenz, M., Frost, N., Schupp, M., Caron, S., Foryst‐Ludwig, A., Böhm, C., Hartge, M., Gust, R., Staels, B., Unger, T., et al. (2008) · Diabetes · doi:10.2337/db07-0839 · Cited by 77 · see citing works
Effect of Fenofibrate on Uric Acid Metabolism and Urate Transporter 1
Uetake, D., Ohno, I., Ichida, K., Yamaguchi, Y., Saikawa, H., Endou, H., & Hosoya, T. (2010) · Internal Medicine · doi:10.2169/internalmedicine.49.2597 · Cited by 73 · see citing works
Edgar, A. D., Tomkiewicz, C., Costet, P., Legendre, C., Aggerbeck, M., Bouguet, J., Staels, B., Guyomard, C., Pineau, T., & Barouki, R. (1998) · Toxicology Letters · doi:10.1016/s0378-4274(98)00042-3 · Cited by 71 · see citing works
Micronized Fenofibrate: A New Fibric Acid Hypolipidemic Agent
Guay, D. R. P. (1999) · Annals of Pharmacotherapy · doi:10.1345/aph.18432 · Cited by 69 · see citing works
Thulin, P., Rafter, I., Stockling, K., Tomkiewicz, C., Norjavaara, E., Aggerbeck, Μ., Hellmold, H., Ehrenborg, E., Andersson, U., Cotgreave, I. A., et al. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.03.007 · Cited by 68 · see citing works
Activation of a novel metabolic gene regulatory pathway by chronic stimulation of skeletal muscle
Cresci, S., Wright, L. D., Spratt, J. A., Briggs, F. N., & Kelly, D. P. (1996) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1996.270.5.c1413 · Cited by 68 · see citing works
Motojima, K. (1993) · Cell Structure and Function · doi:10.1247/csf.18.267 · Cited by 64 · see citing works
Müller, F. U., Arand, M., Frank, H., Seidel, A., Hinz, W., Winkler, L., Hänel, K., Blée, E., Beetham, J. K., Hammock, B. D., et al. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00490.x · Cited by 59 · see citing works
Self-citationInhibition of the aryl hydrocarbon receptor/polyamine biosynthesis axis suppresses multiple myeloma
Bianchi, A., Bagati, A., Fink, E. E., Affronti, H. C., Lipchick, B. C., Moparthy, S., Long, M. D., Rosario, S. R., Lightman, S. M., Moparthy, K., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci70712 · Cited by 56 · see citing works
Kambia, K., Dine, T., Gressier, B., Bah, S., Germe, A.-F., Luyckx, M., Brunet, C., Michaud, L., & Gottrand, F. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00335-1 · Cited by 54 · see citing works
The role of nuclear receptors in regulation of Th17/Treg biology and its implications for diseases
Park, B. V., & Pan, F. (2015) · Cellular and Molecular Immunology · doi:10.1038/cmi.2015.21 · Cited by 50 · see citing works
Dietary Corosolic Acid Ameliorates Obesity and Hepatic Steatosis in KK-Ay Mice
Yamada, K., Hosokawa, M., Yamada, C., Watanabe, R., Fujimoto, S., Fujiwara, H., Kunitomo, M., Miura, T., Kaneko, T., Tsuda, K., et al. (2008) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.31.651 · Cited by 49 · see citing works
Miller, R. T., Glover, S. E., Stewart, W. S., Corton, J. C., Popp, J. A., & Cattley, R. C. (1996) · Carcinogenesis · doi:10.1093/carcin/17.6.1337 · Cited by 47 · see citing works
Ibabe, A., Grabenbauer, M., Baumgart‐Vogt, E., Völkl, A., Fahimi, H. D., & Cajaraville, M. P. (2004) · Acta Histochemica · doi:10.1016/j.acthis.2003.09.002 · Cited by 46 · see citing works
Peroxisome Proliferators: Their Biological and Toxicological Effects
Dzhekova-Stojkova, S., Bogdanska, J., & Stojkova, Z. (2001) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2001.076 · Cited by 44 · see citing works
Kainuma, M., Kasuga, J.-I., Hosoda, S., Wakabayashi, K.-I., Tanatani, A., Nagasawa, K., Miyachi, H., Makishima, M., & Hashimoto, Y. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.03.075 · Cited by 41 · see citing works
Fenofibrate and metabolic syndrome
T. Kraja, A., A. Province, M., J. Straka, R., M. Ordovas, J., B. Borecki, I., & K. Arnett, D. (2010) · Endocrine, Metabolic & Immune Disorders - Drug Targets · doi:10.2174/187153010791213047 · Cited by 40 · see citing works
“Such a role was attributed to the fact that FF activated the peroxisome proliferator-activated receptor alpha (PPAR- ) [17].”
Rao, M. S. R. (2002) · Hepatology Research · doi:10.1016/s1386-6346(01)00119-x · Cited by 40 · see citing works
Parmentier, J. H., Schohn, H., Bronner, M., Ferrari, L., Batt, A. M., Dauça, M., & Kremers, P. G. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00256-6 · Cited by 39 · see citing works
Peroxisome Proliferator‐Activated Receptors: Potential Therapeutic Targets in Lung Disease?
Denning, G. M., & Stoll, L. L. (2005) · Pediatric Pulmonology · doi:10.1002/ppul.20338 · Cited by 37 · see citing works
Lee, B., Hsu, W.-H., Huang, T., Chang, Y., Hsu, Y.-W., & Pan, T. (2013) · Food & Function · doi:10.1039/c3fo60062a · Cited by 30 · see citing works
Andersen, M. E., & Barton, H. A. (1999) · Toxicological Sciences · doi:10.1093/toxsci/48.1.38 · Cited by 30 · see citing works
Kunishima, C., Inoue, I., Oikawa, T., Nakajima, H., Komoda, T., & Katayama, S. (2007) · PPAR Research · doi:10.1155/2007/36092 · Cited by 29 · see citing works
Fraudulent (and non fraudulent) fatty acids for human health
Sirtori, C. R., Galli, C., & Franceschini, G. (1993) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1993.tb01286.x · Cited by 28 · see citing works
Huin‐Schohn, C., Schohn, H., Hatier, R., Bentéjac, M., Antunes, L., Plénat, F., Bugaut, M., & Dauça, M. (2002) · Biology of the Cell · doi:10.1016/s0248-4900(01)01178-9 · Cited by 27 · see citing works
The diagnosis and treatment of primary biliary cirrhosis
Kim, K., & Jeong, S. (2011) · The Korean Journal of Hepatology · doi:10.3350/kjhep.2011.17.3.173 · Cited by 25 · see citing works
Gebel, T., Leister, M., Schumann, W., & Hirsch‐Ernst, K. I. (2002) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/s1383-5718(01)00343-6 · Cited by 24 · see citing works
Self-citationDohmen, K., Tanaka, H., & Haruno, M. (2013) · PubMed · doi:10.15017/1398604 · Cited by 24 · see citing works
IL-17A-targeting fenofibrate attenuates inflammation in psoriasis by inducing autophagy
Park, A., & Heo, T. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121755 · Cited by 21 · see citing works
Peroxisome Proliferator-Activated Receptor ?? and Hypertensive Heart Disease
Goikoetxea, M. J., Beaumont, J., & ez, J. D. (2004) · Drugs · doi:10.2165/00003495-200464002-00003 · Cited by 21 · see citing works
Effects of Switching from Fenofibrate to Pemafibrate for Asymptomatic Primary Biliary Cholangitis
Dohmen, K., Onohara, S.-Y., & Harada, S. (2021) · The Korean Journal of Gastroenterology · doi:10.4166/kjg.2021.092 · Cited by 18 · see citing works
Yaacob, N.-S., Norazmi, M. N., Gibson, G. G., & Kass, G. E. N. (2001) · Toxicology Letters · doi:10.1016/s0378-4274(01)00433-7 · Cited by 18 · see citing works
Ciglitizone and 15d PGJ2 induce apoptosis in Jurkat and Raji cells
Kanunfre, C. C., Freitas, J. J. D. S., Pompéia, C., de Almeida, D. C. G., Cury‐Boaventura, M. F., Verlengia, R., & Curi, R. (2004) · International Immunopharmacology · doi:10.1016/j.intimp.2004.05.007 · Cited by 17 · see citing works
Skrtic, S., Carlsson, L., Ljungberg, A., Lindén, D., Michalik, L., Wahli, W., & Oscarsson, J. (2005) · Liver International · doi:10.1111/j.1478-3231.2004.0998.x · Cited by 17 · see citing works
Tanaka, N., Hora, K., Makishima, H., Kamijo, Y., Kiyosawa, K., Gonzalez, F. J., & Aoyama, T. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00423-x · Cited by 16 · see citing works
Upham, J. P., Acott, P. D., O’Regan, P. A., Sinal, C. J., Crocker, J. F. S., Geldenhuys, L., & Murphy, M. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2007.06.003 · Cited by 14 · see citing works
Ngo, S. N. T., McKinnon, R. A., & Stupans, I. (2003) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/s1532-0456(03)00197-2 · Cited by 14 · see citing works
Vilà, L., Roglans, N., Alegret, M., Camins, A., Pallàs, M., Sánchez, R. M., Vázquez‐Carrera, M., & Laguna, J. C. (2007) · The Journals of Gerontology Series A · doi:10.1093/gerona/62.11.1219 · Cited by 14 · see citing works
Reduction of palmitate-induced cardiac apoptosis by fenofibrate
Kong, J. Y., & Rabkin, S. W. (2004) · Molecular and Cellular Biochemistry · doi:10.1023/b:mcbi.0000012811.89386.a8 · Cited by 13 · see citing works
Role of Thyroid Hormones in Hepatic Effects of Peroxisome Proliferators
Miller, R. T., Scappino, L. A., Long, S. M., & Corton, J. C. (2001) · Toxicologic Pathology · doi:10.1080/019262301301418964 · Cited by 13 · see citing works
Soria, A., González, M. D. C., Vidal, H., Herrera, E., & Bocos, C. (2005) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-005-8145-z · Cited by 13 · see citing works
NSAID-derived γ-secretase modulators. Part III: Membrane anchoring
Baumann, S., Höttecke, N., Schubenel, R., Baumann, K., & Schmidt, B. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.10.035 · Cited by 12 · see citing works
Effect of a pharmacological activation of PPAR on the expression of RAR and TR in rat liver
Bonilla, S., Redonnet, A., Nöel-Suberville, C., Groubet, R., Pallet, V., & Higueret, P. (2001) · Journal of Physiology and Biochemistry · doi:10.1007/bf03179807 · Cited by 12 · see citing works
Wei, P., Kou, W., Fu, J. L., Chen, Z., & Pan, F. (2023) · Communications Biology · doi:10.1038/s42003-023-05104-6 · Cited by 10 · see citing works
Peroxisome proliferators as inducers and substrates of UDP‐glucuronosyltransferases
Magdalou, J., Fournel‐Gigleux, S., Pritchard, M. P., & Siest, G. (1993) · Biology of the Cell · doi:10.1016/s0248-4900(05)80169-8 · Cited by 9 · see citing works
Thorne, P., Byers, D. M., Palmer, F. B. S. C., & Cook, H. W. (1994) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(94)90040-x · Cited by 9 · see citing works
Ngo, S. N. T., McKinnon, R. A., & Stupans, I. (2007) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2007.04.013 · Cited by 8 · see citing works
Tissue-Specific 5′ Heterogeneity of PPARα Transcripts and Their Differential Regulation by Leptin
Garratt, E. S., Vickers, M. H., Gluckman, P. D., Hanson, M. A., Burdge, G. C., & Lillycrop, K. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067483 · Cited by 8 · see citing works
Evidence for a Novel Cardiac-enriched Retinoid X Receptor Partner
Cresci, S., Clabby, M. L., & Kelly, D. P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25668 · Cited by 8 · see citing works
Fidaleo, M., Berardi, E., & Sartori, C. (2008) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2007.11.011 · Cited by 7 · see citing works
Pacot, C., & Latruffe, N. (1993) · Biochimie · doi:10.1016/0300-9084(93)90082-4 · Cited by 7 · see citing works
Roberts, B. J., & Knights, K. M. (1995) · Xenobiotica · doi:10.3109/00498259509061866 · Cited by 7 · see citing works
Kim, N. H., Lee, J., Chon, S., Yu, J. M., Jeong, I., Lim, S. K., Kim, W. J., Song, K., Cho, H., Yu, H. M., et al. (2024) · Endocrinology and Metabolism · doi:10.3803/enm.2024.1995 · Cited by 6 · see citing works
Cortés, V., Quezada, N., Rigotti, A., & Alberto Maiz, G. (2005) · Revista médica de Chile · doi:10.4067/s0034-98872005001200011 · Cited by 6 · see citing works
Waxman, D. J. (1996) · Advances in molecular and cell biology · doi:10.1016/s1569-2558(08)60349-5 · Cited by 6 · see citing works
Beaumont, J., Arias, T., López, B., González, A., Ravassa, S., Hermida, N., Querejeta, R., & Dı́ez, J. (2007) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(07)75252-4 · Cited by 5 · see citing works
Amsaguine, S., Bianchi, A., Collet, P., Huin‐Schohn, C., Jeanvoine, A., Bécuwe, P., Krémarik, P., Domenjoud, L., Keller, J. M., Schohn, H., et al. (2003) · Microscopy Research and Technique · doi:10.1002/jemt.10328 · Cited by 5 · see citing works
Therapeutic potential of PPARα agonist in ligature-induced experimental periodontitis
Chen, Y., & Hu, Y. (2022) · Journal of Applied Oral Science · doi:10.1590/1678-7757-2021-0648 · Cited by 4 · see citing works
Roglans, N., Vilà, L., & Laguna, J. C. (2007) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/s0214-9168(07)74165-7 · Cited by 4 · see citing works
Dohmen, K., Tanaka, H., Haruno, M., & Aishima, S. (2016) · Journal of Gastroenterology and Hepatology Research · doi:10.17554/j.issn.2224-3992.2016.05.635 · Cited by 3 · see citing works
Heydel, J., Garnier, P. E., Fauré, P., & Artur, Y. (2012) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-012-0091-z · Cited by 3 · see citing works
Regulation of Elovl and fatty acid metabolism
Brolinson, A. (2009) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 3 · see citing works
Dose-related effects of the peroxisome proliferator methylclofenapate in rat liver
Lake, B. G., Rumsby, P. C., Cunninghame, M. E., & Price, R. J. (2002) · Environmental Toxicology and Pharmacology · doi:10.1016/s1382-6689(01)00116-8 · Cited by 2 · see citing works
Molecular toxicology of peroxisome proliferators
McNae, F., Sharma, R. K., & Gibson, G. G. (1994) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03188924 · Cited by 2 · see citing works
Carlisle, T. L., Roncero, C., Mounier, C., Thurmond, D. C., & Goodridge, A. G. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37291-6 · Cited by 2 · see citing works
Kambia, K., Dine, T., Gressier, B., Benaji, B., Faouzi, M. E. A., Dupin-Spriet, T., Luyckx, M., & Brunet, C. (2003) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03190488 · Cited by 1 · see citing works
Zubrzycki, A., Wrońska, A., Wierzbicki, P. M., & Kmieć, Z. (2023) · Acta Biochimica Polonica · doi:10.18388/abp.2020_6538 · Cited by 1 · see citing works
- Authors
- Gebel, T., Arand, M., & Oesch, F.
- Affiliations
- Johannes Gutenberg University Mainz (DE)
- Corresponding author
- Arand, Michael
- Venue
- FEBS Letters
- Publisher
- Wiley
- Published
- 1992-08-31
- Volume
- 309
- Issue
- 1
- Pages
- 37-40
- ISSN
- 0014-5793 (ISSN-L)
- 1873-3468
- OpenAlex
- W2094123336
- Cited by
- 106
- References
- 19
- Citations by year
- 2024: 1 · 2023: 3 · 2022: 1 · 2021: 1 · 2018: 1 · 2017: 1 · 2016: 1 · 2015: 2 · 2014: 1 · 2013: 4 · 2012: 2
- FWCI
- 1.57
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- FEBS Letters (publishedVersion)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Keywords
- peroxisome proliferator-activated receptors, fenofibrate, peroxisome proliferation, lipid-lowering drugs, pleiotropy, rat liver
- MeSH terms
- Animals, Base Sequence, Cell Nucleus, Cytosol, Immune Sera, Male, Mice, Inbred BALB C, Mice, Inbred C57BL, Microbodies, Molecular Sequence Data, Oligodeoxyribonucleotides, Fenofibrate, Receptors, Cell Surface, Transcription Factors, Blotting, Northern, Polymerase Chain Reaction, Receptors, Cytoplasmic and Nuclear, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review